This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

At Work and Coping - Effect Study of Workcoping for Patients With Anxiety and Depression (AWaC)

This study is ongoing, but not recruiting participants.
Norwegian Labour and Welfare Administration
Information provided by (Responsible Party):
Uni Research Identifier:
First received: June 1, 2010
Last updated: February 20, 2017
Last verified: February 2017

Mental disorders, mainly various anxiety and depressive disorders, are an increasing reason for sick leave and disability pension. Cognitive behaviour therapy (CBT) has been shown to have an effect on anxiety and depression, but the investigators know little about this in relation to employment. Close follow-up in ordinary employment increase employment participation for serious mental illness, but this is not yet investigated to the same degree for lighter mental disorders.

Center for Work-Coping (No: "Senter for Jobbmestring" - SJM) combines Cognitive behaviour therapy (CBT) and individual placement and support (IPS) and facilitation of work for people with anxiety and depression who are in danger of falling out of work.

The purpose of this project is to evaluate the effectiveness of the model in SJM. The effect will be evaluated through a randomized controlled trial (RCT) in which participants will be randomized to SJM or regular follow-up by The Norwegian Labour and Welfare Administration (NAV) or by their regular general practitioners (GP) and self-help resources. The main outcome measures are work participation with changes in mental health as a secondary outcome.

Condition Intervention Phase
Anxiety Depression Behavioral: Workcoping and IPS Behavioral: Ordinary care by GP or NAV Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: At Work and Coping - Effect Evaluation of Center for Workcoping for Patients With Anxiety and Depression

Resource links provided by NLM:

Further study details as provided by Uni Research:

Primary Outcome Measures:
  • Sick leave data [ Time Frame: One year ]
    The primary outcome of the study is return to work measured through register data.

Secondary Outcome Measures:
  • Psychopathology [ Time Frame: 6 and 12 months of follow up ]
    Secondary outcomes are reductions in psychopathology measured through validated questionnaires (e.g. HADS).

Enrollment: 1202
Study Start Date: June 2010
Estimated Study Completion Date: August 2017
Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Workcoping and IPS
CBT based counseling and supported employment
Behavioral: Workcoping and IPS
Maximum 15 sessions of CBT-based counseling with workcoping as primary focus in addition to work support according to the IPS-model (individual placement and support)
Other Names:
  • Cognitive behavior therapy
  • Cognitive Counseling
Active Comparator: Ordinary care by GP or NAV
Ordinary care by GP or The Norwegian Labour and Welfare Administration (NAV)
Behavioral: Ordinary care by GP or NAV
Ordinary care by the participants physician or the local Labour and Welfare Administration
Other Name: Treatment as usual


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Problems coping with work due to psychological illness (anxiety and depression)
  • Reasonable closeness to work (possible to return within a year)

Exclusion Criteria:

  • Other reasons as primary cause of work problems
  • Serous psychiatric disorders
  • Suicide risk
  • Pregnancy
  • Ongoing psychological treatment (therapy)
  • Ongoing substance abuse
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01146730

Uni Reserach
Bergen, Norway, 5015
Sponsors and Collaborators
Uni Research
Norwegian Labour and Welfare Administration
Principal Investigator: Silje E Reme, PhD Uni Research